Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Referred to the House Committee on Energy and Commerce.
Email me when HRES 1285 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HRES 1285. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The resolution asks the House to recognize that decades of research show mifepristone is safe and effective for medication abortion. It calls on the FDA to base any regulations on peer‑reviewed science and to avoid unnecessary barriers that hurt marginalized patients. The measure reflects concerns about state abortion bans and the need for transparent, evidence‑based policy.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HRES 1285
3 free questions a day, no accountSponsors
- Rep. DeGette, Diana [D-CO-1] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HRES 1285 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HRES 1285 freeOr ask your AI assistant about HRES 1285 directly:
Add to Claude, ChatGPT or Cursor